# Domenico Santoro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/domenico-santoro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,411 |
| Field | Dialysis and Renal Disease Management |
| h-index | 54 |
| i10-index | 219 |
| Last Known Institution | University of Messina |
| OpenAlex ID | https://openalex.org/A5034565443 |
| ORCID iD | 0000-0002-4279-6559 |
| Works | 526 |

## Researcher papers

- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [Vascular access for hemodialysis: current perspectives](https://scholariq.org/papers/vascular-access-for-hemodialysis-current-perspectives/)
- [Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial](https://scholariq.org/papers/rituximab-or-cyclophosphamide-in-the-treatment-of-membranous-nephropathy-the-ri/)
- [The copy number variation landscape of congenital anomalies of the kidney and urinary tract](https://scholariq.org/papers/the-copy-number-variation-landscape-of-congenital-anomalies-of-the-kidney-and/)
- [The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis](https://scholariq.org/papers/the-genetic-architecture-of-membranous-nephropathy-and-its-potential-to-improve/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy](https://scholariq.org/papers/genome-wide-association-analyses-define-pathogenic-signaling-pathways-and/)
- [Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study](https://scholariq.org/papers/treatment-of-metabolic-acidosis-with-sodium-bicarbonate-delays-progression-of/)
- [Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity.](https://scholariq.org/papers/oxidized-ldl-induces-monocytic-cell-expression-of-interleukin-8-a-chemokine-with/)
- [Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis](https://scholariq.org/papers/emerging-therapeutic-strategies-for-minimal-change-disease-and-focal-and/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Researcher university

- [University of Messina](https://scholariq.org/institutions/university-of-messina/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.